Trial intelligence / Profile preview

Juvista for improvement of scar appearance after scar revision surgery

2005-003889-42Phase 2Completed

Sponsor
Renovo
Start
Sep 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in scar comparing Juvista with Placebo (2 arms). Primary endpoint: Total Scar Score. Started Sep 2005; status: completed.

02

Drugs

avotermin
03

Conditions

scar

Beyond the preview

Go deeper on 2005-003889-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003889-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call